An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters

The 2019 novel coronavirus, SARS-CoV-2, first reported in December 2019, has infected over 102 million people around the world as of February 2021 and thus calls for rapid development of safe and effective interventions, namely vaccines. In our study, we evaluated a DNA vaccine against SARS-CoV-2 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Leventhal, Shanna S., Clancy, Chad, Erasmus, Jesse, Feldmann, Heinz, Hawman, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151856/
https://www.ncbi.nlm.nih.gov/pubmed/34065996
http://dx.doi.org/10.3390/microorganisms9051040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151856/
https://www.ncbi.nlm.nih.gov/pubmed/34065996
http://dx.doi.org/10.3390/microorganisms9051040

Ejemplares similares